Only 42 of 183 countries surveyed said their national plans to tackle antimicrobial resistance (AMR) were both financed and implemented, despite 173 countries reporting that they had a plan, according to findings from the World Health Organization’s 2026 global survey reported by Reuters on 16 November. The figures underline a central challenge for Pakistan: turning its own national strategy into sustained surveillance, infection prevention and responsible use of medicines across hospitals, farms and the environment.
The warning comes ahead of World AMR Awareness Week, which runs from 18 to 24 November under the theme “One Health, one action: Prevent AMR now”. Pakistan has a second National Action Plan for Antimicrobial Resistance covering 2024–2028. Its own assessment records progress in laboratory surveillance, but also identifies weaknesses, including the failure of environmental AMR surveillance to advance as envisaged under the previous plan.
Why the latest WHO warning matters
Antimicrobial resistance occurs when bacteria, viruses, fungi or parasites no longer respond to medicines designed to treat them. Antibiotic resistance is one part of the wider problem. When common treatments stop working, infections can become harder to cure and routine procedures such as surgery, cancer treatment and intensive care carry greater risks.
Reuters reported on 16 November that the WHO’s 2026 survey found 173 of 183 countries had national AMR action plans, compared with 79 in 2017. Only 42 countries, however, said their plans were financed and implemented. The survey also found that 69 countries, or 38 per cent, had implemented infection-prevention programmes nationwide. Although 113 countries monitored antibiotic use and 109 tracked resistance, only 21 reported integrating both sets of data.
The distinction between having a plan and carrying it out is important. A strategy can set targets and assign responsibilities, but it cannot reduce infections without trained staff, functioning laboratories, reliable medicines, enforcement, public-health infrastructure and predictable funding.
The WHO’s July 2026 fact sheet says about one in six laboratory-confirmed bacterial infections worldwide was resistant to antibiotics in 2023. In the WHO South-East Asia and Eastern Mediterranean regions, the estimated proportion was about one in three reported infections. Those are regional figures, not a Pakistan-specific rate.
The same WHO fact sheet says bacterial AMR was associated with more than 4.7 million deaths worldwide in 2021, including an estimated 1.14 million deaths directly attributable to resistance. The figures distinguish deaths in which resistance was a contributing factor from those that would not have occurred in the absence of resistance.
What Pakistan’s own data show
Pakistan’s National Action Plan 2.0 cites Institute for Health Metrics and Evaluation estimates that, in 2019, 59,200 deaths in the country were directly attributable to AMR and a further 221,300 were associated with it. These are modelled estimates for 2019, not a count of deaths recorded in hospitals in 2026.
Laboratory surveillance offers another view of the problem. The National Institute of Health’s National AMR Surveillance Report for 2021–2022 says 26 laboratories and surveillance sites submitted data for 2022. The report analysed 229,617 non-duplicate bacterial isolates. Among the reported Escherichia coli isolates, resistance was recorded at 77 per cent for cefotaxime and 75 per cent for ceftriaxone. Among reported Salmonella Typhi isolates, 38 per cent were classified as extensively drug-resistant, while more than 72 per cent were resistant to ceftriaxone.
These figures need careful interpretation. They describe bacteria isolated and tested by participating laboratories, not the percentage of all infections or patients across Pakistan. The report covers 2021 and 2022, so it should be treated as an important historical surveillance baseline rather than a current national estimate. More recent, regularly published and geographically representative data are needed to show whether resistance is rising or falling.
Pakistan has a plan, but surveillance remains uneven
Pakistan’s National Action Plan for Antimicrobial Resistance 2.0, covering 2024–2028, adopts a “One Health” approach. This recognises that resistance can emerge and spread across human health, animal health, food production, agriculture and the environment.
The plan says the Pakistan AMR Surveillance System, launched in 2018, is enrolled in the WHO’s Global Antimicrobial Resistance and Use Surveillance System, with 33 participating laboratories. It also describes pilot surveillance in healthy food animals, including poultry and large ruminants, and outlines strategies for monitoring resistance in diseased animals, aquaculture and the environment.
But the plan also records gaps. It says environmental AMR surveillance under the previous national plan did not progress as envisaged. Its assessment notes that there was no regular surveillance system in the environment sector and that infection-prevention work in health-care settings and communities needed more comprehensive implementation. In human health, the plan identifies weaknesses in standard treatment guidance, national antibiogram development and electronic systems for recording prescriptions and medicine sales.
These are not minor technical details. Without reliable local laboratory results, clinicians may have limited evidence about which antibiotics are likely to work in a particular setting. Without records of how medicines are used, public-health authorities cannot easily identify whether changes in prescribing are linked to changes in resistance.
Why livestock and food systems are part of the problem
Antibiotics and other antimicrobials are used in veterinary care and food production as well as in human medicine. Inappropriate or excessive use can select for resistant organisms in animals. Those organisms or resistance genes can then spread through direct contact, food handling, water and the wider environment.
A peer-reviewed study published in Veterinary Sciences in March 2025 examined Pakistan’s livestock and poultry antimicrobial supply chain. It described a fragmented system, a weak regulatory framework and the absence of systematic monitoring of antimicrobial use in the livestock sector. The study drew on a national stakeholder workshop held in March 2020, so it is best read as an assessment of structural gaps rather than a fresh 2025 census of farm practices. Its findings should be read alongside the national plan, which reports that pilot resistance surveillance in some food animals is under way: monitoring drug use and testing for resistant bacteria are related, but they are not the same activity.
Pakistan’s earlier agriculture and food-sector assessment, published in 2024, also found that implementation of the first national plan had been uneven. It assessed 59 per cent of anticipated activities as covered, while only 12 per cent of evaluated activities were fully executed and documented. The assessment was conducted in 2022 and concerned the 2017–2022 plan; it should not be treated as a score for the current 2024–2028 strategy. It does, however, show why implementation needs to be measured rather than assumed.
What needs to change
First, the national plan needs transparent and sustained financing. Governments should publish which activities have received funds, which laboratories are operational, where surveillance is taking place and whether agreed targets are being met. Federal and provincial authorities also need clear responsibilities and regular public reporting.
Second, surveillance should connect laboratory resistance results with data on antibiotic use. The WHO’s latest global survey shows how few countries currently integrate these datasets. Pakistan’s national and provincial systems need consistent reporting standards, quality-assured testing and wider access to diagnostic services, including outside major urban hospitals.
Third, infection prevention can reduce the need for antibiotics in the first place. Safe water, sanitation, hand hygiene, vaccination, clean health-care facilities, food safety and effective infection-control practices in farms all help prevent infections. Better access to appropriate diagnostics also reduces the risk of treating illnesses with medicines that will not work against them.
Regulation matters too. Prescription rules need to be enforced, veterinary use monitored, and the use of medically important antimicrobials as routine growth promoters controlled in line with international standards. Environmental monitoring and the safe treatment of hospital, pharmaceutical and agricultural waste must become part of the national response.
What people can do — and what antibiotics cannot do
Individuals cannot solve antimicrobial resistance alone, but everyday decisions matter. Antibiotics treat certain bacterial infections; they do not treat viral illnesses such as colds and influenza. People should not start antibiotics without advice from a qualified health professional, use medicines prescribed for someone else or keep leftover antibiotics for a future illness. Anyone prescribed an antibiotic should follow the prescriber’s instructions and seek professional advice if they have concerns or experience side effects.
Vaccination, handwashing, safe food preparation and clean water reduce the risk of infections and therefore the need for antimicrobial treatment. Farmers and animal owners should seek veterinary advice rather than using antibiotics routinely or relying on informal recommendations.
Why better local data matter for Kashmir
For Azad Jammu and Kashmir (AJK), the national picture is a starting point, not a substitute for local evidence. The NIH’s 2021–2022 report lists Abbas Institute of Medical Sciences in Muzaffarabad as a public-sector sentinel site in both 2021 and 2022. It also lists Provincial Headquarters Hospital in Gilgit as a sentinel site in 2022. However, the report presents its resistance findings at national level rather than publishing separate AJK and Gilgit-Baltistan resistance profiles.
Hospitals and laboratories in AJK and Gilgit-Baltistan need dependable access to culture testing, referral networks and up-to-date local antibiograms. Smaller facilities in mountainous districts may face practical barriers to transporting samples and receiving timely results. These are reasons to strengthen regional diagnostic links, not grounds for assuming that resistance rates in one part of Pakistan apply to every valley or district.
The Azadi Times has also examined the wider relationship between environmental conditions and public health in its recent report on Lahore’s smog crisis. AMR adds another dimension: the health of people, animals, food systems and the environment is interconnected.
A test of implementation, not another announcement
World AMR Awareness Week begins on 18 November, but awareness campaigns alone cannot preserve the effectiveness of life-saving medicines. The WHO’s updated Global Action Plan for 2026–2036 calls for coordinated action across human, animal, plant and environmental health. Pakistan has already set out a national framework for that work.
The next measure of progress should be visible in funded programmes, better access to diagnostics, stronger infection prevention, responsible prescribing and public data that show what is changing. For Pakistan — including AJK and Gilgit-Baltistan — the challenge is no longer simply to recognise antimicrobial resistance. It is to build a system capable of detecting it early, limiting its spread and ensuring that effective treatment remains available when people need it.
Sources and further reading
- Reuters, 16 November 2026: WHO says antimicrobial-resistance efforts remain off track for 2030 goals
- WHO, 16 July 2026: Antimicrobial resistance fact sheet
- WHO: Pakistan National Action Plan for Antimicrobial Resistance 2.0 (2024–2028)
- Government of Pakistan: National Action Plan for Antimicrobial Resistance 2.0
- National Institute of Health: National AMR Surveillance Report, Pakistan 2021–2022
- Veterinary Sciences, 1 March 2025: Evaluation of antimicrobial usage supply chain and monitoring in Pakistan’s livestock and poultry sector
- Antibiotics, 22 February 2024: Assessment of Pakistan’s first AMR National Action Plan in agriculture and food sectors
- WHO: World AMR Awareness Week 2026, 18–24 November
- WHO, 25 May 2026: Updated Global Action Plan on AMR 2026–2036
- US Centers for Disease Control and Prevention: Healthy habits — antibiotic do’s and don’ts


